FREDERICK, Md., Aug. 16 /PRNewswire-FirstCall/ -- BioElectronics Corporation (Pink Sheets: BIEL) is a developer and marketer of drug-free, patches that enable faster patient recovery from swelling due to soft tissue injuries. The Company announced today it has entered into an agreement with Zeon Healthcare Ltd., Oxfordshire U.K. for distribution of ActiPatch for heel pain into the retail market in the United Kingdom.
"Heel pain is a prevalent and under-treated condition in the UK and elsewhere," says Todd Kislak, President of BioElectronics' Orthopedic Group. Kislak adds that, "ActiPatch is a simple and effective solution for the UK and Irish consumer to safely treat plantar fasciitis and other inflammatory foot conditions. RSP is 29.99 pounds Sterling and lasts for up to 720 hours. Pain release for a few pence per day.
"Zeon's track record of performance and reliability makes them the ideal partner for our expansion into the international markets."
Zeon is a healthcare distributor with a portfolio of products including Podiatry, Skin care, Cardiology and supplements.
Zeon's clients include the major Pharmacy chains, Grocery multiples, Podiatrists and Chiropodists throughout the UK and Ireland
Zeon is delighted to be working with BioElectronics in the area of heel pain and welcomes enquiries on ActiPatch Therapy. Ivan Lythgoe, Sales Director of Zeon said today, "ActiPatch(TM) is a remarkable product that brings a whole new technology to the management and relief of heel pain. There is no comparable product at all in these markets and we anticipate that the demand will be huge."
ActiPatch(TM) is a drug-free anti-inflammatory patch with an embedded battery operated microchip that delivers weeks of continuous pulsed therapy for a few pence a day. The unique ActiPatch delivery system, using patented technology, provides a cost-effective, patient friendly method to reduce swelling, and the appearance of related side-effects, in post-surgical and muscular-skeletal conditions.
For more information visit http://www.bioelectronicscorp.com/
Safe Harbor Statement:
This news release contains forward-looking statements related to future growth and earnings opportunities. Such statements are based upon certain assumptions and assessments made by management of both companies in light of current conditions, expected future developments and other factors it believes to be appropriate. Actual results may differ as a result of factors over which the companies have no control.
© 2005 PR Newswire
